LAURINO, ELENIA
 Distribuzione geografica
Continente #
NA - Nord America 146
AS - Asia 103
EU - Europa 74
SA - Sud America 15
AF - Africa 8
OC - Oceania 1
Totale 347
Nazione #
US - Stati Uniti d'America 142
SG - Singapore 51
IT - Italia 42
CN - Cina 22
BR - Brasile 14
HK - Hong Kong 13
VN - Vietnam 10
DE - Germania 7
SE - Svezia 7
CI - Costa d'Avorio 4
FR - Francia 3
GB - Regno Unito 3
IN - India 3
BD - Bangladesh 2
BE - Belgio 2
CA - Canada 2
ES - Italia 2
FI - Finlandia 2
PL - Polonia 2
SN - Senegal 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
DO - Repubblica Dominicana 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NI - Nicaragua 1
PH - Filippine 1
RU - Federazione Russa 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 347
Città #
Ashburn 30
Dallas 25
Singapore 24
Santa Clara 17
San Jose 16
Hong Kong 12
Beijing 7
Shanghai 7
Ho Chi Minh City 6
Pisa 6
Milan 5
New York 5
Rome 5
Abidjan 4
Boardman 4
Frankfurt am Main 4
Livorno 4
Cermenate 3
Chandler 3
London 3
Mira 3
Orem 3
Bientina 2
Brussels 2
Buffalo 2
Colombo 2
Dakar 2
Fairfield 2
Florence 2
Helsinki 2
Los Angeles 2
Miami 2
Montecatini Terme 2
North Bergen 2
Ogden 2
Pescia 2
Quanzhou 2
Vicopisano 2
Warsaw 2
Americana 1
Aracaju 1
Ashland 1
Atlanta 1
Augusta 1
Bremen 1
Brooklyn 1
Camboriú 1
Campos dos Goytacazes 1
Capão da Canoa 1
Casablanca 1
Chennai 1
Columbus 1
Denver 1
Düsseldorf 1
General Pacheco 1
Haiphong 1
Hanoi 1
Hefei 1
Hyderabad 1
Itapetininga 1
Johannesburg 1
Lawrence 1
Managua 1
Medford 1
Miano 1
Mumbai 1
Nuremberg 1
Pedreira 1
Phoenix 1
Phú Nhuận 1
Presidente Prudente 1
Princeton 1
Ribeirão das Neves 1
Salvador 1
Santa Vitória do Palmar 1
Santo Domingo 1
Seattle 1
Simolândia 1
Sydney 1
São Paulo 1
Taguig 1
Toronto 1
Vancouver 1
Viareggio 1
Vienna 1
Wilmington 1
Totale 277
Nome #
Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies 142
COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases 136
ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study in Central-Italy. 63
Environmental triggers for idiopathic inflammatory myopathies: unravelling the known and unknown 7
Anifrolumab Therapy in Dermatomyositis: New Insights From Refractory Patients 5
The Role of Ultrasound Pleural Irregularities in the Identification of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies 3
Totale 356
Categoria #
all - tutte 1.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 0 0 1 1 0 0 0 2 3
2022/202330 2 5 2 1 1 4 0 6 9 0 0 0
2023/202447 1 3 6 6 6 4 4 1 3 1 6 6
2024/2025109 3 5 13 6 8 12 6 3 17 10 12 14
2025/2026163 10 21 19 21 18 9 15 6 4 23 17 0
Totale 356